First AI Breast Cancer Prediction Platform Receives FDA Authorization
Clairity Breast Predicts Women’s Five-Year Future Risk Of Breast Cancer
Clairity’s "first-in-class" mammography-based AI screening tool, Clairity Breast, provides "equitable risk assessments," expanding access to lifesaving early detection for breast cancer, said company founder Connie Lehman.
